Literature DB >> 16905517

Patient safety and inpatient glycemic control: translating concepts into action.

Richard Hellman1.   

Abstract

OBJECTIVE: (1) To summarize current knowledge regarding patient safety issues and their impact on inpatient glycemic control and (2) to provide a systematic and practical approach to improving patient safety in this area.
METHODS: Insulin delivery in inpatient settings is examined, as are the barriers to safe insulin therapy. A distinction is made between safety strategies of proven value and those that are less useful. Characteristics of safer insulin algorithms are discussed.
RESULTS: Errors in insulin administration remain a common cause of injuries. Despite strong evidence of the dangers of sliding-scale insulin regimens in inpatient settings, sliding-scale insulin regimens remain a widely used but ineffective (and occasionally dangerous) method. To correctly analyze inpatient processes of care, a systems approach is needed, and the relationship between quality of care, latent medical errors, injurious patient errors, and patient safety must be understood. In complex systems such as hospitals, catastrophic error has complex roots involving many individuals, and the design of the system often has latent flaws that make human error likely, even predictable. The concept of the scope of awareness is useful in understanding why it is ineffective to focus only on those at the point of care, and how improvement is more apt to occur with a team approach and the evaluation of systemic factors, at the "blunt end" of care. Error-prone organizations are often very unsafe, and certain practices tend to be common among them. Data are now available showing the negative impact of poorly supervised trainees and the extent of the problem worldwide on patient safety.
CONCLUSION: Redesign of patient care provided in hospitals regarding glucose control is long overdue. Practical strategies are given that focus on improving patient safety for the patient needing inpatient glycemic control. Such techniques now have a sufficient evidentiary base. Therefore, hospitals should move rapidly to make euglycemia a goal for all inpatients, and to make patient safety in glycemic control a reality, not just for a few, but for all patients in our care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905517     DOI: 10.4158/EP.12.S3.49

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  6 in total

1.  Reduction of Insulin Related Preventable Severe Hypoglycemic Events in Hospitalized Children.

Authors:  Amy Poppy; Claudia Retamal-Munoz; Melanie Cree-Green; Colleen Wood; Shanlee Davis; Scott A Clements; Shideh Majidi; Andrea K Steck; G Todd Alonso; Christina Chambers; Arleta Rewers
Journal:  Pediatrics       Date:  2016-06-17       Impact factor: 7.124

2.  Risk factors for hospital-acquired 'poor glycemic control': a case-control study.

Authors:  Matthew D McHugh; Jingjing Shang; Douglas M Sloane; Linda H Aiken
Journal:  Int J Qual Health Care       Date:  2010-11-16       Impact factor: 2.038

3.  Can Smart Pens Help Improve Diabetes Management?

Authors:  Sarah L Sy; Medha M Munshi; Elena Toschi
Journal:  J Diabetes Sci Technol       Date:  2020-10-21

4.  Inpatient hypoglycemia: a challenge that must be addressed.

Authors:  Leslie Eiland; Whitney Goldner; Andjela Drincic; Cyrus Desouza
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

5.  Addressing Inpatient Glycaemic Control with an Inpatient Glucometry Alert System.

Authors:  J N Seheult; A Pazderska; P Gaffney; J Fogarty; M Sherlock; J Gibney; G Boran
Journal:  Int J Endocrinol       Date:  2015-07-28       Impact factor: 3.257

6.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Authors:  Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.